Madeleine Noble1, Caryl Russell, Lori Kraemer, Michael Sharratt. 1. Department of Kinesiology, Faculty of Applied Health Sciences, University of Waterloo, 200 University Ave W., Waterloo, ON N2L 3G1, Canada. uwfitness@uwaterloo.ca
Abstract
PURPOSE: The purpose of this study is to report physical function and quality of life data collected from cancer patients who participated in a supervised exercise intervention at the UW WELL-FIT program over 5 years. METHODS: Five hundred seventy-five participants from 18 to 84 years of age (mean, 54 years) were assessed and enrolled in the 24-session program while currently receiving treatment for cancer. Twice weekly, they participated in aerobic exercise, resistance training and stretching exercises for 1 h each time. Pre- and post-assessments were performed to document changes in physical function, while the short form-36 (SF-36) survey assessed changes in quality of life. RESULTS: Three hundred eighty-six participants completed the program, while 171 withdrew at some point over the 24 sessions. Pre- and post-cardiovascular assessments were performed on 305 (78.4%) participants. There was a significant increase in the maximum work rate attained and significant decreases in heart rate response, systolic blood pressure and rate of perceived exertion at the submaximal level (p < 0.01). The summary component scales of SF-36 (physical and mental) were significantly improved as well as all eight subscales (p < 0.01). CONCLUSIONS: The data collected from this program indicate that a comprehensive physical activity program involving cardiovascular exercise, resistance training and flexibility can significantly improve physical function and various quality of life indices for individuals undergoing treatment for cancer.
PURPOSE: The purpose of this study is to report physical function and quality of life data collected from cancerpatients who participated in a supervised exercise intervention at the UW WELL-FIT program over 5 years. METHODS: Five hundred seventy-five participants from 18 to 84 years of age (mean, 54 years) were assessed and enrolled in the 24-session program while currently receiving treatment for cancer. Twice weekly, they participated in aerobic exercise, resistance training and stretching exercises for 1 h each time. Pre- and post-assessments were performed to document changes in physical function, while the short form-36 (SF-36) survey assessed changes in quality of life. RESULTS: Three hundred eighty-six participants completed the program, while 171 withdrew at some point over the 24 sessions. Pre- and post-cardiovascular assessments were performed on 305 (78.4%) participants. There was a significant increase in the maximum work rate attained and significant decreases in heart rate response, systolic blood pressure and rate of perceived exertion at the submaximal level (p < 0.01). The summary component scales of SF-36 (physical and mental) were significantly improved as well as all eight subscales (p < 0.01). CONCLUSIONS: The data collected from this program indicate that a comprehensive physical activity program involving cardiovascular exercise, resistance training and flexibility can significantly improve physical function and various quality of life indices for individuals undergoing treatment for cancer.
Authors: B A Cunningham; G Morris; C L Cheney; N Buergel; S N Aker; P Lenssen Journal: JPEN J Parenter Enteral Nutr Date: 1986 Nov-Dec Impact factor: 4.016
Authors: Lis Adamsen; Morten Quist; Julie Midtgaard; Christina Andersen; Tom Møller; Lasse Knutsen; Anders Tveterås; Mikael Rorth Journal: Support Care Cancer Date: 2005-08-12 Impact factor: 3.603
Authors: Kerry S Courneya; Christine M Friedenreich; H Arthur Quinney; Anthony L A Fields; Lee W Jones; Jeffrey K H Vallance; Adrian S Fairey Journal: Ann Behav Med Date: 2005-04
Authors: Kerry S Courneya; Roanne J Segal; Karen Gelmon; Robert D Reid; John R Mackey; Christine M Friedenreich; Caroline Proulx; Kirstin Lane; Aliya B Ladha; Jeffrey K Vallance; Qi Liu; Yutaka Yasui; Donald C McKenzie Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-12 Impact factor: 4.254
Authors: K S Courneya; C M Friedenreich; H A Quinney; A L A Fields; L W Jones; A S Fairey Journal: Eur J Cancer Care (Engl) Date: 2003-12 Impact factor: 2.520
Authors: D Santa Mina; D Au; J Brunet; J Jones; G Tomlinson; N Taback; D Field; A Berlingeri; H Bradley; D Howell Journal: Curr Oncol Date: 2017-10-25 Impact factor: 3.677
Authors: Amy A Kirkham; Sarah E Neil-Sztramko; Joanne Morgan; Sara Hodson; Sarah Weller; Tasha McRae; Kristin L Campbell Journal: Support Care Cancer Date: 2015-01-25 Impact factor: 3.603
Authors: D Santa Mina; A Petrella; K L Currie; K Bietola; S M H Alibhai; J Trachtenberg; P Ritvo; A G Matthew Journal: Curr Oncol Date: 2015-12 Impact factor: 3.677
Authors: M A Dalzell; N Smirnow; W Sateren; A Sintharaphone; M Ibrahim; L Mastroianni; L D Vales Zambrano; S O'Brien Journal: Curr Oncol Date: 2017-06-27 Impact factor: 3.677